β-amyloid, microglia, and the inflammasome in Alzheimer's disease.
β-amyloid, microglia, and the inflammasome in Alzheimer's disease.
复制标题
DOI:
10.1007/s00281-015-0518-0
复制
发表时间:
2015-11
影响因子:
9
通讯作者:
El Khoury J
中科院分区:
文献类型:
--
作者:
Gold M;El Khoury J
There is extensive evidence that accumulation of mononuclear phagocytes including microglial cells, monocytes and macrophages at sites of β-amyloid (Aβ) deposition in the brain is an important pathological feature of Alzheimer’s disease (AD) and related animal models, and the concentration of these cells clustered around Aβ deposits is several folds higher than in neighboring areas of the brain. Microglial cells phagocytose and clear debris, pathogens and toxins, but they can also be activated to produce inflammatory cytokines, chemokines and neurotoxins. Over the past decade, the roles of microglial cells in AD have begun to be clarified and we proposed that these cells play a dichotomous role in the pathogenesis of AD. Microglial cells are able to clear soluble and fibrillar Aβ, but continued interactions of these cells with Aβ can lead to an inflammatory response resulting in neurotoxicity. Inflammasomes are inducible high molecular weight protein complexes that are involved in many inflammatory pathological processes. Recently, Aβ was found to activate the NLRP3 inflammasome in microglial cells in vitro and in vivo thereby defining a novel pathway that could lead to progression of AD. In this manuscript we review possible steps leading to Aβ-induced inflammasome activation and discuss how this could contribute to the pathogenesis of AD.